Web Results



Mecasermin (INN) (trade name Increlex) is recombinant human insulin-like growth factor 1 (IGF-I), which is used for the long-term treatment of growth failure in ...

Mecasermin: Indications, Side Effects, Warnings - Drugs.com


Easy to read patient leaflet for mecasermin. Includes indications, proper use, special instructions, precautions, and possible side effects.

Increlex (Mecasermin [rDNA origin] Injection): Side Effects ... - RxList


Jun 16, 2014 ... INCRELEX® (mecasermin [rDNA origin] injection) contains human insulin-like growth factor-1 (rhIGF-1) produced by recombinant DNA ...

Increlex (Mecasermin [rDNA origin] Injection) Patient Information ...


Pictures of Increlex (Mecasermin [rDNA origin] Injection), drug imprint information , side effects for the patient.

Mecasermin - Side Effects, Dosage, Interactions | Everyday Health


Nov 5, 2014 ... Mecasermin is a man-made form of insulin-like growth factor-1 (IGF-1), a substance that is normally produced in the body. IGF-1 is important for ...

Increlex - FDA


INCRELEX® (mecasermin [rDNA origin] injection) number of cases indicative of anaphylaxis requiring hospitalization have been reported. Parents and patients ...

Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin ... - Aetna


Aetna considers mecasermin (Increlex) and mecasermin rinfabate (Iplex)* medically necessary for the treatment of growth failure in children with severe primary ...

INCRELEX, INN: mecasermin - European Medicines Agency


INCRELEX (mecasermin) is recombinant human insulin-like growth factor-1 ... Mecasermin was granted orphan status in the EU for “Treatment of growth ...

Mecasermin (Subcutaneous Route) Description and Brand Names ...


Apr 1, 2015 ... Mecasermin injection is a man-made version of insulin-like growth factor-1 (IGF-1 ) hormone. IGF-1 is produced in the liver and plays an ...

Mecasermin (recombinant human insulin-like growth factor I). - NCBI


Adv Ther. 2009 Jan;26(1):40-54. doi: 10.1007/s12325-008-0136-5. Epub 2009 Jan 28. Mecasermin (recombinant human insulin-like growth factor I).

More Info

DrugBank: Mecasermin


May 16, 2007 ... Description, Mecasermin contains recombinant-DNA-engineered human insulin- like growth factor-1 (rhIGF-1). IGF-1 consists of 70 amino acids ...

Increlex (mecasermin) - CenterWatch


Increlex (mecasermin): For the treatment of growth failure due to Primary IGFD. New approved drug details including side effects, uses and general information.



Manufacturer's information about recombinant human insulin-like growth factor-1, marketed under the brand name Increlex (generic name mecasermin).